Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation
Open Access
- 12 June 2006
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 38 (3), 211-216
- https://doi.org/10.1038/sj.bmt.1705416
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaBlood, 2006
- Therapies for Relapsed Hodgkin Lymphoma: Transplant and Non-Transplant Approaches Including ImmunotherapyHematology-American Society Hematology Education Program, 2005
- Utility of FDG-PET scanning in lymphoma by WHO classificationBlood, 2003
- Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialThe Lancet, 2002
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975